Grit Biotechnology
Works in Cardiovascular · Dermatology · Hematology · Immunology · Infectious disease · Oncology · Renal & urogenital · Respiratory · Women's health
Grit Biotechnology is a clinical trial sponsor. It has 19 active clinical trials with 604 planned participants, across 9 therapeutic areas. Since 2021 it has completed 0 trials and stopped 11 early.
Trial track record · since 2021
Pipeline · 19 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Grit Biotechnology
Grit Biotechnology is lead sponsor of 19 active clinical trials on ClinicalTrials.gov, with 604 planned participants, in Cardiovascular, Dermatology, Hematology, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 11 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Grit Biotechnology; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-18.
Approve Suite is not affiliated with Grit Biotechnology.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.